4UK Prospective Diabetes Study Group.UK prospective diabetes study 16:Overview of 6 years therapy of type diabetes,a progressive disease[J].Diabetes,1995,44:1249 -1258.
5PURRELLO F,RABUAZZA AM.Metabolic factors that affect beta-cell function and survival[J].Diabet Nutr Metab,2000,13(2):84-91.
6Continuous subcutaneous insulin infusion at 25 years:evidence base for the expanding use of insulin pump therapy in type 1 diabetes[J].Diabetes Care,2002,25(3):593-598.Review.
7Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus[J].Pediatr Endocrinol Metab,2002,15(7):1005-1010.
8KAHN SE.The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus[J].Am J Med,2000,108(Suppl 6a):2-8.
9SVITIZ WI.Lipotoxicity and glucotocicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(1):55-59,63-64.
